Developing long-acting growth hormone formulations

被引：26

作者：

Cawley, Pippa ^{[1
]}

Wilkinson, Ian ^{[1
]}

Ross, Richard J. ^{[1
]}

机构：

[1] Univ Sheffield, Acad Unit Diabet Endocrinol & Reprod, Sheffield S10 2RX, S Yorkshire, England

来源：

CLINICAL ENDOCRINOLOGY | 2013年 / 79卷 / 03期

关键词：

PREPARATION NUTROPIN DEPOT; GH PREPARATION; PHARMACODYNAMIC CHARACTERISTICS; FACTOR-I; PHARMACOKINETICS; CHILDREN; EFFICACY; LB03002; FUSION; SAFETY;

D O I：

10.1111/cen.12240

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Daily recombinant growth hormone (GH) restores normal growth and body composition in GH-deficient children and adults; however, daily injections are inconvenient and can be distressing for some children. On top of this compliance is a problem in up to 75% of children. Developing long-acting GH formulations has proved challenging, and questions remain regarding safety and efficacy. In this review, we focus on the rationale for generating long-acting GH agonists and the technologies being developed to deliver prolonged exposure to GH.

引用

页码：305 / 309

页数：5

共 32 条

[1]

Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children [J].

Achermann, JC ;

Brook, CGD ;

Robinson, ICAF ;

Matthews, DR ;

Hindmarsh, PC .

CLINICAL ENDOCRINOLOGY, 1999, 50 (03) :301-308

[2]

Bailey, 2012, ENDOCR REV, V33, pOR29

[3]

Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency [J].

Bidlingmaier, Martin ;

Kim, John ;

Savoy, Conrad ;

Kim, Myung J. ;

Ebrecht, Nils ;

de la Motte, Stephan ;

Strasburger, Christian J. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :2926-2930

[4]

Biller B. M., 2012, PITUITARY

[5]

Effects of Once-Weekly Sustained-Release Growth Hormone: A Double-Blind, Placebo-Controlled Study in Adult Growth Hormone Deficiency [J].

Biller, Beverly M. K. ;

Ji, Hyi-Jeong ;

Ahn, Hyunji ;

Savoy, Conrad ;

Siepl, E. Christine ;

Popovic, Vera ;

Coculescu, Mihail ;

Roemmler, Josefine ;

Gavrila, Catalin ;

Cook, David M. ;

Strasburger, Christian J. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06) :1718-1726

[6]

A novel long-acting human growth hormone fusion protein (vrs-317): enhanced in vivo potency and half-life [J].

Cleland, Jeffrey L. ;

Geething, Nathan C. ;

Moore, Jerome A. ;

Rogers, Brian C. ;

Spink, Benjamin J. ;

Wang, Chai-Wei ;

Alters, Susan E. ;

Stemmer, Willem P. C. ;

Schellenberger, Volker .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (08) :2744-2754

[7]

The pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (Nutropin Depot) in GH-deficient adults [J].

Cook, DM ;

Biller, BMK ;

Vance, ML ;

Hoffman, AR ;

Phillips, LS ;

Ford, KM ;

Benziger, DP ;

Illeperuma, A ;

Blethen, SL ;

Attie, KM ;

Dao, LN ;

Reimann, JD ;

Fielder, PJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4508-4514

[8]

Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth [J].

Cutfield, Wayne S. ;

Derraik, Jose G. B. ;

Gunn, Alistair J. ;

Reid, Kyle ;

Delany, Theresa ;

Robinson, Elizabeth ;

Hofman, Paul L. .

PLOS ONE, 2011, 6 (01)

[9]

Long-acting pegylated human GH in children with GH deficiency: a single-dose, dose-escalation trial investigating safety, tolerability, pharmacokinetics and pharmacodynamics [J].

de Schepper, Jean ;

Rasmussen, Michael Hojby ;

Gucev, Zoran ;

Eliakim, Alon ;

Battelino, Tadej .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) :401-409

[10]

Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand-receptor fusions [J].

Ferrandis, Eric ;

Pradhananga, Sarbendra L. ;

Touvay, Caroline ;

Kinoshita, Carol ;

Wilkinson, Ian R. ;

Stafford, Kevin ;

Wu, Zida ;

Strasburger, Christian J. ;

Sayers, Jon R. ;

Artymiuk, Peter J. ;

Ross, Richard J. .

CLINICAL SCIENCE, 2010, 119 (11-12) :483-491

← 1 2 3 4 →